Chris Compton

1.4k total citations
29 papers, 345 citations indexed

About

Chris Compton is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Sociology and Political Science. According to data from OpenAlex, Chris Compton has authored 29 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 21 papers in Physiology and 2 papers in Sociology and Political Science. Recurrent topics in Chris Compton's work include Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers), Asthma and respiratory diseases (21 papers) and Respiratory Support and Mechanisms (13 papers). Chris Compton is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (29 papers), Asthma and respiratory diseases (21 papers) and Respiratory Support and Mechanisms (13 papers). Chris Compton collaborates with scholars based in United States, United Kingdom and Canada. Chris Compton's co-authors include David A. Lipson, Lee Tombs, Neil Barnes, Robert Suruki, Emma Hilton, Sarah Landis, Ian Naya, Bernardino Alcázar Navarrete, Ana R. Sousa and Paul Jones and has published in prestigious journals such as SHILAP Revista de lepidopterología, Respiratory Research and Drugs & Aging.

In The Last Decade

Chris Compton

28 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Compton United States 11 333 270 23 9 8 29 345
Rajat Mohindra United Kingdom 5 281 0.8× 217 0.8× 13 0.6× 11 1.2× 4 0.5× 7 304
Catherine Francisco Italy 4 610 1.8× 482 1.8× 28 1.2× 7 0.8× 2 0.3× 6 628
Christie Arrasate United Kingdom 3 398 1.2× 307 1.1× 19 0.8× 9 1.0× 3 0.4× 6 411
Denise Till Switzerland 7 571 1.7× 489 1.8× 21 0.9× 18 2.0× 5 0.6× 11 595
В Е Ноников Russia 3 472 1.4× 401 1.5× 12 0.5× 14 1.6× 3 0.4× 5 494
Chris Compton United States 10 438 1.3× 306 1.1× 14 0.6× 5 0.6× 3 0.4× 46 460
Alessandro Guasconi Italy 6 474 1.4× 357 1.3× 17 0.7× 12 1.3× 1 0.1× 23 493
Ruby Birk United States 6 339 1.0× 258 1.0× 13 0.6× 6 0.7× 6 0.8× 14 349
H Prunier Italy 2 390 1.2× 299 1.1× 15 0.7× 7 0.8× 1 0.1× 4 399
Kiernan DeAngelis United States 8 346 1.0× 255 0.9× 11 0.5× 11 1.2× 2 0.3× 17 360

Countries citing papers authored by Chris Compton

Since Specialization
Citations

This map shows the geographic impact of Chris Compton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Compton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Compton more than expected).

Fields of papers citing papers by Chris Compton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Compton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Compton. The network helps show where Chris Compton may publish in the future.

Co-authorship network of co-authors of Chris Compton

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Compton. A scholar is included among the top collaborators of Chris Compton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Compton. Chris Compton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Halpin, David, Surya P. Bhatt, Marc Miravitlles, et al.. (2024). Impact of varying health status thresholds on disease stability in COPD with FF/UMEC/VI: IMPACT post hoc analysis. PA1173–PA1173. 1 indexed citations
2.
Herth, Felix, Claus Vogelmeier, Franziska Trudzinski, et al.. (2024). Unmet needs in patients with COPD in Germany: a retrospective, cross-sectional study. ERJ Open Research. 11(3). 976–2024. 1 indexed citations
3.
Ismaila, Afisi, Katrin Haeussler, Vanita Tongbram, et al.. (2022). Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis. Advances in Therapy. 39(11). 4961–5010. 7 indexed citations
4.
Rothnie, Kieran, et al.. (2022). Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England. International Journal of COPD. Volume 17. 1455–1466. 5 indexed citations
5.
6.
7.
Singh, Dave, James F. Donohue, I. Boucot, et al.. (2021). Future concepts in bronchodilation for COPD: dual-versusmonotherapy. European Respiratory Review. 30(160). 210023–210023. 7 indexed citations
8.
Bourbeau, Jean, Mona Bafadhel, Neil Barnes, et al.. (2021). Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD. International Journal of COPD. Volume 16. 499–517. 17 indexed citations
9.
Hizawa, Nobuyuki, Koichi Fukunaga, Hisatoshi Sugiura, et al.. (2021). A Prospective Cohort Study to Assess Obstructive Respiratory Disease Phenotypes and Endotypes in Japan: The TRAIT Study Design. International Journal of COPD. Volume 16. 1813–1822. 4 indexed citations
10.
Sansbury, Leah B., et al.. (2021). Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England. International Journal of COPD. Volume 16. 2591–2604. 11 indexed citations
11.
Ferguson, Gary T., Nicola J. Brown, Chris Compton, et al.. (2020). Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials. Respiratory Research. 21(1). 131–131. 26 indexed citations
12.
Hartley, Benjamin, Neil Barnes, Sally Lettis, et al.. (2020). Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis. Respiratory Research. 21(1). 5–5. 20 indexed citations
13.
Naya, Ian, Lee Tombs, David A. Lipson, I. Boucot, & Chris Compton. (2019). Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis. Respiratory Research. 20(1). 60–60. 10 indexed citations
14.
Whittaker, Hannah, Hana Müllerová, Deborah Jarvis, et al.. (2019). <p>Inhaled corticosteroids, blood eosinophils, and FEV<sub>1</sub> decline in patients with COPD in a large UK primary health care setting</p>. International Journal of COPD. Volume 14. 1063–1073. 13 indexed citations
15.
16.
Worsley, Sally, David Halpin, Dawn Midwinter, et al.. (2019). Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design. ERJ Open Research. 5(4). 61–2019. 11 indexed citations
17.
Tombs, Lee, Michael J. Asmus, I. Boucot, et al.. (2018). Efficacy of Umeclidinium/Vilanterol in Elderly Patients with COPD: A Pooled Analysis of Randomized Controlled Trials. Drugs & Aging. 35(7). 637–647. 5 indexed citations
18.
Navarrete, Bernardino Alcázar, I. Boucot, Ian Naya, et al.. (2018). Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis. Pulmonary Therapy. 4(2). 171–183. 14 indexed citations
19.
Feldman, Gregory, Ana R. Sousa, David A. Lipson, et al.. (2017). Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study. Advances in Therapy. 34(11). 2518–2533. 72 indexed citations
20.
Landis, Sarah, Robert Suruki, Emma Hilton, Chris Compton, & N. W. Galwey. (2017). Stability of Blood Eosinophil Count in Patients with COPD in the UK Clinical Practice Research Datalink. COPD Journal of Chronic Obstructive Pulmonary Disease. 14(4). 382–388. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajat Mohindra Breakdown of academic impact, for papers by Catherine Francisco Breakdown of academic impact, for papers by Christie Arrasate Breakdown of academic impact, for papers by Denise Till Breakdown of academic impact, for papers by В Е Ноников Breakdown of academic impact, for papers by Chris Compton Breakdown of academic impact, for papers by Alessandro Guasconi Breakdown of academic impact, for papers by Ruby Birk Breakdown of academic impact, for papers by H Prunier Breakdown of academic impact, for papers by Kiernan DeAngelis
Rankless by CCL
2026